Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma.
D000230:Adenocarcinoma / Q000276:immunology; D000328:Adult; D000367:Age Factors; D000368:Aged; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral / Q000032:analysis; D002277:Carcinoma / Q000209:etiology / Q000276:immunology* / Q000532:radiotherapy / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D003168:Complement Fixation Tests; D000939:Epitopes; D005006:Ethnicity; D005260:Female; D006801:Humans; D008875:Middle Aged; D018139:Simplexvirus / Q000276:immunology*; D012959:Socioeconomic Factors; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000276:immunology* / Q000532:radiotherapy / Q000601:surgery
D000956:Antigens, Viral; D000939:Epitopes